View allAcnéApplication topiqueArticlesCollection de livres anciens de dermatologieCongrèsCysteamine Crème DépigmentanteDermatologie dans les maladies infectieusesDermatologie dans les maladies systémiquesDistribution géographique des visitesEpilation au laserExplication de traitements pour le patientGroupes d'entraide et AssociationsAvis de prise en chargeLes kératoses séborrhéiques (verrues séborréiques)(verrues séniles)(taches de vieillesse)Injection de toxine botulique, d'acide hyaluronique et peelingsLa lèpre (maladie de Hansen)L'alcool et la peau (éthylisme)Le cholestérol et la peauLe mésothéliome et la peauLes compagnies lasers et leurs appareils médicaux utilisés en dermatologieLes laboratoires cosmétiquesLes laboratoires pharmaceutiques et leurs médicaments utilisés en dermatologieLiens académiquesL'Industrie au service de la DermatologieNotes de congrès/conférencesPolémiquePoliticiensPrésentationsProfessionnelsStars de CinémaSujets dermatologiques spécialisésTélédermatologieHistoire & TerminologieTokelau (Dermatophytose imbriquée)Traducteur de langage dermatologique médicalTraitements non-médicamenteuxTraitements physiquesVIPsVoie orale
Date Name
DescAsc

Monde – Villes d’où proviennent les visites (01-08.2010)

The Global Dermatology Information Portal has been visited in the following cities: A Aarschot Aberdeen Abidjan AbuDhabi Abuja Accra ActonVale Adapazari Addison Adelaide Adger AdisAbeba Adliswil Agadir Agen Agincourt Aiken Aix-en-Provence Ajaccio Akron Al-Jubayl Al-Uqsur Alameda Alamogordo AlbaIulia Albany Albert Albi Aldershot Alencon Ales Alesund AlexanderCity Alexandria Alfortville Algiers Algolsheim Alicante Allenwood Alleur Allston Alma…

Details
Distribution géographique des visites

Afrique – Pays d’où proviennent les visites (01-08.2010)

The Global Dermatology Information Portal has been visited in the following countries/territories: Algeria Angola Benin Botswana Burkina Faso Burundi Cameroon Cape Verde Chad Comoros Congo (DRC and Republic) Cote d’Ivoire Djibouti Egypt Ethiopia Gabon Gambia Ghana Kenya Lesotho Liberia Libya Madagascar Mali Mauritania Mauritius Mayotte Morocco Niger Nigeria Rwanda Réunion Sénégal Seychelles South Africa Sudan…

Details
Distribution géographique des visites

Amérique du Nord et Amérique du Sud – Pays d’où proviennent les visites (01-08.2010)

The Global Dermatology Information Portal has been visited in the following countries/territories: Argentina Bolivia Brazil Canada CaymanIslands Chile Colombia Costa Rica Cuba DominicanRepublic Ecuador French Guiana Guadeloupe Guatemala Haiti Martinique Mexico Netherlands Antilles Nicaragua Panama Paraguay Peru PuertoRico SantaLucia SaintPierreetMiquelon United States of America (USA) Venezuela The top 5 countries/territories with the most visitors are:…

Details
Distribution géographique des visites

La lèpre (maladie de Hansen) – Traitement (Pour les professionnels)

I. Anti-leprosy treatments Modern treatment for leprosy was introduced in 1941 when dapsone and its derivatives were used. Prior to that, the segregation of patients in a leprosarium by law was intended to prevent the spread of leprosy to the community. With effective chemotherapy, leprosy is curable today and treatment is undertaken by the general…

Details
La lèpre (maladie de Hansen)

Asie – Pays d’où proviennent les visites (01-08.2010)

The Global Dermatology Information Portal has been visited in the following countries/territories: Afghanistan Armenia Bahrain Bangladesh Cambodia China Cyprus Georgia Hong Kong Indonesia India Iran Iraq Israel Japan Kuwait Laos Lebanon Macau Malaysia Myanmar(Birmanie) Nepal Oman Pakistan Philippines Qatar Saudi Arabia Singapore South Korea Sri Lanka Syria Taiwan Tajikistan Thailand Turkey United Arab Emirates  (UAE)…

Details
Distribution géographique des visites

La lèpre (maladie de Hansen) – Complications (Pour les professionnels)

The importance of leprosy lies in its ability to cause permanent disabilities from damage to nerves and eyes. Nerve damage can be due to granulomatous lesions that result in fibrosis, during reactions when severe inflammation results in nerve destruction and from ischaemia caused by pressure on the vasa nervosa. . The residual nerve deficit that…

Details
La lèpre (maladie de Hansen)

La lèpre (maladie de Hansen) – Diagnostic (Pour les professionnels)

Histological examination of the skin lesion and nerve for the typical histological changes and the presence of acid-fast bacilli is required for the definitive diagnosis of leprosy. All cases of leprosy should preferably be confirmed histologically as labeling a person with leprosy carries with it dire social and medical implications. Slit skin smear to detect…

Details
La lèpre (maladie de Hansen)

La lèpre (maladie de Hansen) – Caractéristiques cliniques (Pour les professionnels)

Leprosy primarily affects the skin and nerves of humans. The lesions may be remarkably asymptomatic even after years of existence. However, some patients develop reactions resulting in painful cutaneous lesions accompanied by fever, malaise and other symptoms. Most frequently the first signs develop on the skin, even though the nerve is always involved simultaneously. In…

Details
La lèpre (maladie de Hansen)

La lèpre (maladie de Hansen) – La maladie et son classement (Pour les professionnels)

The type of disease developed is partially linked to the HLA genes: HLA DR2 and HLA DR3 predispose to tuberculoid disease and HLA–Mt1 to lepromatous disease. Environmental factors such as poor nutrition and poor sanitation play a role through altered immunity in a yet ill-understood mechanism. Human disease results from formation of granulomas in the…

Details
La lèpre (maladie de Hansen)